Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation

被引:17
作者
Vines, CM [1 ]
Xue, M [1 ]
Maestas, DC [1 ]
Cimino, DF [1 ]
Prossnitz, ER [1 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA
关键词
D O I
10.4049/jimmunol.169.12.6760
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One of the major functions of the N-formyl peptide receptor (FPR) is to mediate leukocyte degranulation. Phosphorylation of the C-terminal domain of the FPR is required for receptor internalization and desensitization. Although arrestins mediate phosphorylation-dependent desensitization, internalization, and initiation of novel signaling cascades for a number of G protein-coupled receptors, their roles in FPR regulation and signaling remain unclear. CXCR1-mediated degranulation of RBL-2H3 cells is promoted by arrestin binding. To determine whether receptor phosphorylation or arrestin binding is required to promote FPR-mediated degranulation, we used RBL-2H3 cells stably transfected with either the wild-type FPR or a mutant form, DeltaST, which is incapable of undergoing ligand-stimulated phosphorylation. We observed that stimulation of wild-type FPR resulted in very low levels of degranulation compared with that mediated by cross-linking of the FcepsilonRI receptor. Stimulation of the DeltaST mutant, however, resulted in levels of degranulation comparable to those of the FcepsilonRI receptor, demonstrating that neither receptor phosphorylation nor arrestin binding was necessary to initiate FPR-mediated degranulation. Degranulation initiated by the DeltaST mutant was proportional to the level of active cell surface receptor, suggesting that either receptor internalization or desensitization may be responsible for terminating degranulation of the wild-type FPR. To distinguish between these possibilities, we used a partially phosphorylation-deficient mutant of the FPR that can undergo internalization, but not desensitization. Degranulation by this mutant FPR was indistinguishable from that of the DeltaST mutant, indicating that FPR phosphorylation or binding of arrestin but not internalization terminates the degranulation response.
引用
收藏
页码:6760 / 6766
页数:7
相关论文
共 23 条
[1]   Cutting edge: Differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation [J].
Ahamed, J ;
Haribabu, B ;
Ali, H .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3559-3563
[2]   Chemoattractant receptor cross-desensitization [J].
Ali, H ;
Richardson, RM ;
Haribabu, B ;
Snyderman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6027-6030
[3]  
ALI H, 1994, J BIOL CHEM, V269, P24557
[4]  
ALI H, 1993, J BIOL CHEM, V268, P24247
[5]  
ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882
[6]   Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCRI [J].
Barlic, J ;
Andrews, JD ;
Kelvin, AA ;
Bosinger, SE ;
DeVries, ME ;
Xu, LL ;
Dobransky, T ;
Feldman, RD ;
Ferguson, SSG ;
Kelvin, DJ .
NATURE IMMUNOLOGY, 2000, 1 (03) :227-233
[7]   β-Arrestins regulate interleukin-8-induced CXCR1 internalization [J].
Barlic, J ;
Khandaker, MH ;
Mahon, E ;
Andrews, J ;
DeVries, ME ;
Mitchell, GB ;
Rahimpour, R ;
Tan, CM ;
Ferguson, SSG ;
Kelvin, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16287-16294
[8]   Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding [J].
Bennett, TA ;
Foutz, TD ;
Gurevich, VV ;
Sklar, LA ;
Prossnitz, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49195-49203
[9]   Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase [J].
Daaka, Y ;
Luttrell, LM ;
Ahn, S ;
Della Rocca, GJ ;
Ferguson, SSG ;
Caron, MG ;
Lefkowitz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :685-688
[10]   The Frizzled-1/β2-adrenergic receptor chimera:: pharmacological properties of a unique G protein-linked receptor [J].
DeCostanzo, AJ ;
Huang, XP ;
Wang, HY ;
Malbon, CC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (05) :341-348